Company: PolyPid Ltd.
Ticker: Nasdaq: PYPD
Sector: Healthcare
Investor Contact: Ben Shamsian

PolyPid News

News

PolyPid Announces Receipt of Nasdaq Minimum Bid Price Notification

PETACH TIKVA, Israel, Dec. 09, 2022 -- PolyPid Ltd. (Nasdaq: PYPD) ("PolyPid" or the "Company"), a late-stage biopharma company aiming to improve surgical outcomes, today announced it has received a written notice (the "Notice") from Nasdaq Stock Market LLC ("Nasdaq")...

PolyPid Announces Cost Reduction Plan

Reduction of Approximately 20% in Organization Headcount Company Expects to Extend Cash Runway into Q3 2023 PolyPid Intends to Discuss Regulatory Pathway for D-PLEX100 for Prevention of Surgical Site Infections in Abdominal Surgery with U.S. and EU Regulatory...

Skip to content